Molecular Diagnostics Market (By Product- instruments, reagents, software & services, Market By Technology– polymerase chain reactions (PCR), hybridization, DNA sequencing, microarray, Market By Application- infectious diseases, oncology, genetic testing, blood screening, Market By End User- hospitals, laboratories) - Global Industry Size, Share, Trends, and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 150

Introduction

The molecular diagnostic is a method which is used to identify and examine nucleic acids or proteins at a molecular level. This method is used to evaluate the genetic makeup to an individual to identify predisposition to a particular disease to condition and detect it. This method is mainly used to diagnose disease and risk occurred.  It also mainly used to decide the therapies which are suitable for the individual patients.

Market Dynamics

Growing prevalence of infectious diseases & cancers, rising awareness and acceptance of personalized medicines, increase in the biomarker identification, and improvement in molecular diagnostics are some of the major factors driving the growth of the market. Additionally, technological advancement in molecular diagnostics is also responsible to drive the market, as they provide greater accuracy, portability, and cost effectiveness. Moreover, rise in funding by governments and various organizations in the clinical studies in the molecular diagnosis space is expected to propel the growth of the market. Increasing geriatric population is also one of the major factor boosting the growth of the market.

However, stringent regulatory necessities for the approval of recent molecular diagnostics methods are some of the restraining factors hampering the growth of the market. Additionally, the market consists of several opportunities such as rising adoption of the molecular diagnostics in the developing economies.

Market Classification and Overview

The global molecular diagnostics market is segmented into product, technology, application, end-user, and region.

On the basis of product, the market is segmented into instruments, reagents, software & services.

On the basis of technology, the market is segmented into polymerase chain reactions (pcr), hybridization, DNA sequencing, microarray, and others.

Based on the application, the market is segmented into infectious diseases, oncology, genetic testing, blood screening, and others

On the basis of end-user, the market is segmented into hospitals, laboratories, and others.

Regional Overview

Geographically, the global molecular diagnostics market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is expected to be the largest region during the forecast period 2018-2026 owing to the presence of well-established diagnostic infrastructure and technological improvements in the field of molecular diagnostics.

Asia Pacific is expected to drive significantly during the forecasted period owing to the presence of large targeted population and high unmet clinical needs. Moreover, the increasing government initiatives in the countries such as India and China, to develop health infrastructure us likely to propel the growth of the market in this region.

Europe is expected to hold the major share during the forecast period 2018-2026 owing to the rising incidences of lifestyles and infectious diseases attached with favorable demographic trend such as geriatric population. Growing awareness regarding the advantages of early diagnostics is further likely to propel the growth of the market in this region.

LAMEA is expected to witness a steady growth during the forecasted period due to the lack of knowledge and poor infrastructure development.

Report Coverage

Market

Molecular Diagnostics Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Product, Technology, application, End-User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The molecular diagnostics market comprises of some of the major players such as

  • Abbott Molecular Cepheid
  • BioMerieux’s
  • Roche diagnostics
  • Danaher Corporation
  • Siemens Healthcare
  • Qiagen Gaithersburg
  • Johnson and Johnson
  • Agilent (Dako)
  • GenMark diagnostics
  • Analytik Jena and Alere Inc.

For instance, in November 2017, Hummingbird Diagnostics GmbH and Saarland University collaborated in early disease detection based on molecular markers.

Market Segmentation

Market By Product

  •  Instruments
  • Reagents
  • Software & Services

Market By Technology

  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Others

Market By Application

  •  Infectious Diseases
  • Oncology
  • Genetic Testing
  • Blood Screening
  • Others

Market By End-User

  • Hospital
  • Laboratories
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Systemic Lupus Erythematosus Market (By Drug Classes: NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, Biologics; ByRoute of Administration, Oral, Intravenous, Subcutaneous) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Systemic lupus erythematosus market size is anticipated to around USD 2.7 billion by 2026, this market is anticipated to grow with 7.0% CAGR during the forecast time period. Market Dynamics Biologics for autoimmune conditions enhance treatment to a hug

Continuous Glucose Monitoring (CGM) Systems/Devices Market (By Component: Transmitters & Receivers, Sensors, Insulin Pumps; By End-use: Hospitals, Homecare Settings, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Continuous Glucose Monitoring (CGM) Systems/Devices market size is anticipated to around USD 2.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period. Market Dynamics Developing instances of diabetes, comb

Multiparameter Patient Monitoring Market (By Type: Fixed, Portable; By Acuity Level: High-Acuity, Mid-Acuity, Low-Acuity; By Age Group: Adult, Pediatric, Geriatric; By End Use: Hospitals, Homecare Settings, Ambulatory Surgical Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Multiparameter patient monitoring system is a solution that helps healthcare centres to enhance and improve clinical performance. The multiparameter patient monitors are available in a broad range. The multiparameter patient monitors have various functions such as drug dose calculation, pace detection, paediatric, adult and neonatal monitoring and night mode facility. The report provides analy

Cranial Implants Market (By Product: Non-Customized Cranial Implants, Customized Cranial Implants; By Material: Ceramic, Polymer, Metal; By End-user: Specialty Neurosurgery Centers, Hospitals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global cranial implants industry size is examined and is anticipated to value around USD 1.5 billion by the end of 2026. The market is anticipated to develop with a CAGR of 6.4% during the forthcoming years. Market Dynamics The global cranial implants market is d

Chronic Obstructive Pulmonary Disease Treatment Market (By Drug Class: Bronchodilators, Combination, Phosphodiesterase Type 4 Inhibitors, Mucokinetics, Corticosteroids, Others; By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global chronic obstructive pulmonary disease treatment market income is anticipated to value around USD 24.3 billion by the end of 2026. The market is anticipated to develop with a CAGR of 4.9% between the years 2018 to 2026. Market Dynamics The market is driven

Cancer Diagnostics Market (By Type: Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy, Others (barium enema); By Application: Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global cancer diagnostics market size is studied and is anticipated to value around USD 250.3 billion by the end of 2026. The market is anticipated to develop with a CAGR of 7.2% during the forthcoming years. Market Dynamics Developing predominance of oncologic c

Cart Summary